Navigation Links
Lombardi research: Monoclonal antibodies primed to become potent immune weapons against cancer
Date:3/20/2009

r (Erbitux, Avastin), lung cancer (Avastin), and blood cancers (Rituxan, Campath), but they have appeared to primarily work by forcing tumor related receptors to shut down pro-growth signals, Weiner says.

"For years it has been presumed that the ability of antibodies to interfere with malignant cell-related signaling is the dominant mechanism of anticancer activity, but we have also known that the normal job of an antibody is to deliver an antigen to the body's immune system which then destroys the target," Weiner says.

Recent research by Weiner and others, however, now shows that antibodies can inhibit function not only as signaling manipulators but also as initiators of immune responses that leads to control of cancer, the authors say.

"We believe that Herceptin and Rituxan, as examples, work in part by immunizing people against cancer, but at this point, the magnitude of that response is variable and is frequently very small," Weiner says.

Scientists now believe that it will be possible to alter the antibodies so that they induce both kinds of human immunity the innate immune response that is short-lasting and which directly kills tumor cells, and a long-lasting "memory" response that comes from the adaptive immune response. "We have long thought that monoclonal antibodies are capable of stimulating the innate immune system, but we now have evidence that the therapy can prime an adaptive response as well. Such responses would make the treatment much more powerful, capable of keeping cancer under control," he says.

"For the first time we are using technology that can measure the immune response that is occurring in monoclonal antibody treatment, and which will help us build better antibodies that amplify and shape that immune response to become more powerful," Weiner says.

And in the future, it may be possible to build antibodies that are targeted to existing targets on a patient's tumor, as well as to tar
'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
215-514-9751
Georgetown University Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Harmonizing biobank research: An achievable world-wide goal
2. Toothsome research: Deducing the diet of a prehistoric hominid
3. K-State research: Freshwater pollution costs US at least $4.3 billion a year
4. Geisinger research: Antimalarial drug prevents diabetes in arthritis patients
5. Robotics research: Enhancing the lives of people with disabilities
6. Advances in the field of schizophrenia research: New genetic factors identified
7. New research: Fruit juice consumption not related to overweight in children
8. Paradigm shift in Alzheimerss research: new treatments
9. Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses
10. Scientists identify human monoclonal antibodies effective against bird, seasonal flu viruses
11. Evolution in action: Our antibodies take evolutionary leaps to fight microbes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... N.C. , Jan. 22, 2015 Infinisource has launched ... of the G2 model. The G2 sets a higher standard ... iSolved human capital management solution. With plug-and-play installation, touch screen ... time clock provides a robust time collection solution for the ...
(Date:12/22/2014)... Holiday Season may be the brightest ever for the ... long anticipated floodgates for consumer biometrics may finally be ... tablets, and wearable mobile devices that incorporate biometrics will ... nearly 4.8 billion biometric devices by 2020.   ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... LAFAYETTE, Ind. - Proper and timely burning of some Eastern ... a wide range of species, a Purdue University report shows. ... nutrient from deep in the soil and depositing it on ... an important source of nutrition for a variety of species ...
... been a hot savanna region for at least the past ... hominids evolved in this areasays a team of researchers led ... findings may shed light on the evolutionary pressures that led ... develop a more slender physique, and sweat more copiously than ...
... , New Rochelle, NY, June 8, 2010The growing use ... may help individuals with diabetes optimize blood glucose control ... with diabetes, as described in a Special Supplement to ... published by Mary Ann Liebert, Inc. (http://www.liebertpub.com). The issue ...
Cached Biology News:Fire may be key to reviving dogwood trees in Eastern forests 2East-African human ancestors lived in hot environments, says Caltech-led team 2East-African human ancestors lived in hot environments, says Caltech-led team 3Importance of insulin delivery devices for diabetes management 2
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq:   ... disease, announced today that the Company closed its ... Investment Management, Jack W. Schuler , Birchview ... were $10.5 million, before offering expenses.  The proceeds ...
(Date:12/24/2014)... December 23, 2014 GMO corn cases filed ... are in the process of being consolidated in a Kansas ... Re: Syngenta AG MIR 162 Corn Litigation, MDL No. 2591 ... , Management of the Syngenta GMO corn multidistrict litigation (MDL) ...
(Date:12/24/2014)... 23, 2014 On Friday, December 19, ... Omnibus and Continuing Resolution Appropriations Act of 2015, which ... to receive funding through the Congressionally Directed Medical Research ... The Hydrocephalus Association (HA), working in conjunction with its ...
(Date:12/24/2014)... Nashville Fertility Center announced that Dr. ... Society for Reproductive Medicine (ASRM), a leading professional organization committed ... his new role as treasurer, Dr. Hill also fills a ... in furthering the mission of ASRM. , Dr. Hill ...
Breaking Biology Technology:Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3
... Xybion Medical ... its Research and Development facility in Fair Lawn, New Jersey. , ... Cedar Knolls, NJ (PRWEB) August 3, 2009 -- Xybion ... of Pristima™ the premier preclinical solution on the market, is pleased to announce that SK ...
... , , , ... Inc. (Nasdaq: GHDX ) today reported financial results and business progress ... revenue increased to $36.6 million in the second quarter of 2009 compared with ... Onco type DX(R) breast cancer test was $35.2 million in the second ...
... 4 /PRNewswire-Asia/ -- Shanghai ChemPartner Co., Ltd.,(ChemPartner) a wholly ... moved its drug discovery collaboration with ELARA,Pharmaceuticals to a ... the areas of DMPK, pharmacology and toxicology for ELARA,s ... from both sides will,work closely together to design and ...
Cached Biology Technology:SK Life Sciences has Licensed Pristima 2Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 2Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 3Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 4Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 5Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 6Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 7Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 8Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 9Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level 2